Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Dye-based vs virtual chromoendoscopy for pouch surveillance in FAP

Official title: ENDOPOL: Dye chromoENDOscopy Versus Virtual Chromoendoscopy for Assessment of the Ileo-anal Pouch in Patients With Familial Adenomatous POLyposis: a Randomized Controlled Trial

Run by London North West Healthcare NHS Trust · NCT07726771 · Data updated 2026-11-12

This trial tests whether dye-based chromoendoscopy or virtual chromoendoscopy better detects adenomas during routine pouchoscopy in adults with FAP and an ileal pouch-anal anastomosis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorLondon North West Healthcare NHS Trust
Academic / other
Locations1 site (London, London)
StatusRecruiting
StartedJuly 9, 2026
Main results expectedJuly 9, 2031
Study endsJuly 9, 2031
Registry record updatedJuly 24, 2026
Trial IDNCT07726771 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with FAP who have an IPAA and are undergoing routine surveillance pouchoscopy at participating centers.

Probably not a fit

Patients whose adenoma risk or anatomy limits benefits from advanced imaging approaches may see little difference between techniques.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international, multicenter randomized trial compares dye-based chromoendoscopy using Indigo Carmine with virtual chromoendoscopy (NBI/BLI) during surveillance pouchoscopy in adults with familial adenomatous polyposis and an ileal pouch-anal anastomosis. Participants are randomized 1:1 to either technique and undergo their usual endoscopic surveillance, with any adenomas treated as per standard practice during the same procedure. The study aims to generate high-quality evidence to inform the preferred chromoendoscopy approach in this setting, where current guidelines are inconclusive. The anticipated duration is about two years, and procedures are performed by endoscopists experienced in FAP).

Why it matters

Potential benefit: If successful, the trial could identify a superior imaging approach that improves adenoma detection during pouch surveillance.

How similar studies have gone: Evidence in other endoscopic settings supports improved visualization with advanced imaging, but this direct comparison in FAP pouch surveillance is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

ALL of the following:

1. Diagnosis of FAP i.e., at least one of following:

   * Genetic diagnosis: proven APC germline mutation OR
   * Clinical diagnosis: \>100 colorectal adenomas in combination with a positive family history of FAP
2. Have an ileal-pouch anal anastomosis (IPAA), either after primary proctocolectomy or secondary proctectomy after initial colectomy and ileorectal or ileosigmoidal anastomosis (IRA/ISA)
3. Age ≥ 18 years

Exclusion Criteria:

ANY of the following

1. Diagnosis of FAP i.e., at least one of following:

   * Genetic diagnosis: proven APC germline mutation OR
   * Clinical diagnosis: \>100 colorectal adenomas in combination with a positive family history of FAP
2. Have an ileal-pouch anal anastomosis (IPAA), either after primary proctocolectomy or secondary proctectomy after initial colectomy and ileorectal or ileosigmoidal anastomosis (IRA/ISA)
3. Age ≥ 18 years

Where it's running

  • St Mark's Hospital Polyposis Registry (St Mark's Centre for Familial Intestinal Cancer)
    London, London, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Andre Latchford, MBBS PhD FRCP — London North West University Healthcare Nhs Trust
  • Study coordinator: Andrew Latchford, MBBS PhD FRCP
  • Email: andrew.latchford@nhs.net
  • Phone: +442088643232

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.